Alison Freeman-Gleason

Of Counsel
afreemangleason@cooley.com
Full contact info

I enjoy being part of our clients’ teams, working closely with them to understand their goals, and bringing my 25+ years of experience to structure, draft and negotiate agreements that help fulfill those goals.

About Alison

Alison, previously a partner at Cooley, focuses her practice on intellectual property transactions and complex commercial contracting in the life sciences sector. She has experience in a wide variety of transactions, particularly in complicated cross-border licensing and strategic collaborations, including global co-development, co-promotion and profit-sharing arrangements, international distribution, technology acquisition and other highly negotiated transactions.

View full bio

Experience

LIXTE Announces Three-Way Clinical Trial Agreement With GSK and MD Anderson

LIXTE Announces Three-Way Clinical Trial Agreement With GSK and MD Anderson

September 20, 2023

Cooley advised LIXTE Biotechnology, a clinical-stage pharmaceutical company focused on developing and commercializing new cancer therapies, on its clinical trial agreement with The University of Texas MD Anderson Cancer Center and GSK.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle
Matthew Langer
Senior Counsel , New York

Related Practices & Industries

Life Sciences
Life Sciences Corporate Partnering & Licensing
Intellectual Property

Bridge to Life Sells Certain Assets to TransMedics

Bridge to Life Sells Certain Assets to TransMedics

August 3, 2023

Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics.

Read more

Related contacts

Rowook Park
Partner, San Diego
Jenny Ge
Associate, San Francisco
Alison Freeman-Gleason
Of Counsel, Seattle
Melissa Meza
Associate, San Diego
Lauren Creel
Partner, Palo Alto
Patrick Pang
Associate, New York
Rishab Kumar
Partner, Palo Alto
Jonathan Rivinus
Partner, Colorado
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Andrew Epstein
Special Counsel, Seattle
Justin Kisner
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Joseph J. Kim
Associate, Palo Alto
Jameson Davis
Associate, Palo Alto
Daniel Lac
Associate, San Diego
Cara Buchicchio
Associate, New York
Ajay Athavale
Associate, San Francisco
Xenia Chiu
Associate, Singapore
Mor Agam
Associate, New York
Rubin Waranch
Associate, Washington DC
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Mergers & Acquisitions
Life Sciences
Intellectual Property
Venture Capital
Debt Finance
Tax
Healthcare, Life Sciences, FDA & EU Regulatory
Employment & Labor
Antitrust & Competition
Compensation & Benefits

Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma

Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma

October 13, 2021

Cooley advised Otsuka Pharmaceutical, a global healthcare company, on its worldwide collaboration and license agreement with biopharmaceutical company Sunovion Pharmaceuticals and parent company Sumitomo Dainippon Pharma for the joint development and commercialization of four novel candidate compounds. Lawyers Alison Freeman-Gleason and Brian Stalter led the Cooley team advising Otsuka.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle
J. Brian Stalter
Special Counsel, New York
Jacqueline Grise
Partner, Washington DC
David Burns
Special Counsel, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Georgina Dietrich
Associate, Brussels
Jan Lang
Associate, Brussels
Marc Suskin
Partner, New York

Related Practices & Industries

Life Sciences Corporate Partnering & Licensing
Life Sciences
Antitrust & Competition
Arbitration

Molecular Templates Enters Collaboration With Bristol Myers Squibb for Cancer Treatment

Molecular Templates Enters Collaboration With Bristol Myers Squibb for Cancer Treatment

February 26, 2021

Cooley advised clinical-stage biopharmaceutical company, Molecular Templates (MTEM), on its strategic research collaboration with Bristol Myers Squibb to discover and develop therapies designed for specific oncology targets. The collaboration will seek to discover new molecules utilizing MTEM’s next-generation engineered toxin body (ETB) platform. Lawyers Alison Freeman-Gleason and Kristy Brady led the Cooley team advising MTEM.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle

Related Practices & Industries

Life Sciences
Life Sciences Corporate Partnering & Licensing

SELLAS Life Sciences Group to Merge with Galena Biopharma

SELLAS Life Sciences Group to Merge with Galena Biopharma

April 8, 2017

Cooley advised SELLAS Life Sciences Group on its merger agreement with Galena Biopharma.

Read more

Related contacts

Yvan-Claude Pierre
Partner, New York
Matthew D. Silverman
Special Counsel, San Diego
Ben Beerle
Partner, San Francisco
Garth Angelo Osterman
Partner, San Francisco
Jacqueline Grise
Partner, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Alison Freeman-Gleason
Of Counsel, Seattle
Natasha Leskovsek
Of Counsel, Washington DC
Sarah Lightdale
Partner, New York
Aaron Pomeroy
Partner, Colorado
Ian Shapiro
Partner in Charge – New York, New York

Related Practices & Industries

Mergers & Acquisitions
Life Sciences
View more

Memberships & affiliations

Washington State Bar Association